Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis

[1]  Binjie Zhang,et al.  Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages , 2012, Journal of Cell Science.

[2]  A. Choi,et al.  Autophagy: a core cellular process with emerging links to pulmonary disease. , 2011, American journal of respiratory and critical care medicine.

[3]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[4]  Adam Kiezun,et al.  Computational and statistical approaches to analyzing variants identified by exome sequencing , 2011, Genome Biology.

[5]  Fred A. Wright,et al.  Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 , 2011, Nature Genetics.

[6]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[7]  G. Cutting,et al.  Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients , 2010, Respiratory research.

[8]  N. Schork,et al.  Extremes of Unexplained Variation as a Phenotype: An Efficient Approach for Genome-Wide Association Studies of Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.

[9]  E. Zeggini,et al.  An Evaluation of Statistical Approaches to Rare Variant Analysis in Genetic Association Studies , 2009, Genetic epidemiology.

[10]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[11]  Margaret Rosenfeld,et al.  Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. , 2009, Contemporary clinical trials.

[12]  T. Noda,et al.  Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. , 2008, Cell structure and function.

[13]  L. Dupont,et al.  Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre , 2006, European Respiratory Journal.

[14]  M. Kosorok,et al.  Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. , 2005, JAMA.

[15]  F. Martinez,et al.  Automated high-throughput sex-typing assay. , 2004, BioTechniques.

[16]  P. Gøtzsche,et al.  Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?—A 30‐year Cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection , 2004, Pediatric pulmonology.

[17]  R. Gibson,et al.  Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[18]  M. Denton,et al.  Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[19]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.